- Oct 31, 2022
A stem cell protein facilitates relapse of pediatric brain tumors
The malignant brain tumor type medulloblastoma can become resistant to therapy which can cause relapse. Researchers have discovered a...
- Oct 7, 2022
Study Investigates Potential Embryonic Origin of Medulloblastomas
Medulloblastomas may exist in a premalignant form at birth after initially developing during the first or second trimester of pregnancy,...
- Jul 18, 2022
Brain Cancer Therapy Shows Promise in Pediatric Clinical Trial
A new antibody therapy for children with medulloblastoma has shown promise during a Phase I clinical trial. The antibody, which targets a...
- Jul 9, 2021
New generation anti-cancer drug shows promise for children with brain tumours
A genetic map of an aggressive childhood brain tumour called medulloblastoma has helped researchers identify a new generation ...
- Jul 6, 2021
Cancer neuroscientists identify a key culprit behind pediatric brain cancer’s spread
Now, research led by USC investigators has shined new light on how medulloblastoma travels to other sites within the central nervous ...
- Jun 25, 2021
Searching for the cell of origin of childhood brain cancer
A study coordinated by the University of Trento may have identified the cell of origin of medulloblastoma, a malignant tumor in...
- Jun 15, 2021
Study sheds light on treatment options for devastating childhood brain cancer
A national study led by Washington University School of Medicine in St. Louis and St. Jude Children's Research Hospital suggests that...
- May 21, 2021
Targeting abnormal cell metabolism shows promise for treating pediatric brain tumors
Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness...